Rankings
▼
Calendar
INVA
Innoviva, Inc.
$1B
Q2 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$64M
-4.4% YoY
Gross Profit
$64M
100.0% margin
Operating Income
$60M
93.2% margin
Net Income
$38M
58.9% margin
EPS (Diluted)
$0.34
QoQ Revenue Growth
+16.2%
Cash Flow
Operating Cash Flow
$56M
Free Cash Flow
$56M
Stock-Based Comp.
$474,000
Balance Sheet
Total Assets
$642M
Total Liabilities
$396M
Stockholders' Equity
$227M
Cash & Equivalents
$142M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$64M
$67M
-4.4%
Gross Profit
$64M
$67M
-4.4%
Operating Income
$60M
$63M
-4.7%
Net Income
$38M
$55M
-30.9%
← FY 2019
All Quarters
Q3 2019 →
INVA Q2 2019 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena